Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group. Read more about Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group.
Cabozantinib: An evolving therapy for hepatocellular carcinoma. Read more about Cabozantinib: An evolving therapy for hepatocellular carcinoma.
Management of locally recurrent nasopharyngeal carcinoma. Read more about Management of locally recurrent nasopharyngeal carcinoma.
The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: What do we know and where are we going? Read more about The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: What do we know and where are we going?
Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors. Read more about Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors.
Management of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm. Read more about Management of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm.
Radiotherapy plus adjuvant goserelin improves survival in men with poor prognosis prostate cancer. Read more about Radiotherapy plus adjuvant goserelin improves survival in men with poor prognosis prostate cancer.
Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation. Read more about Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation.
